BIO-RAD LABORATORIES, INC. — Director's Dealing 2023

May 1, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2023-04-29

Reporting Person: RAMALINGAM AJIT (SVP, Chief Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-04-29	Bio-Rad A Common Stock	M	277	—	Acquired	294.3520	Direct
2023-04-29	Bio-Rad A Common Stock	F	96	$450.7900	Disposed	198.3520	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-29	Restricted Stock Units	$0	M	277	Disposed		Bio-Rad A Common Stock (277)	Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Includes 17.3520 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2023.

F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F4: On April 29, 2020, the reporting person was granted 1,384 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.